Allergen-specific immunotherapy as a modern method in the therapy of atopic dermatitis without added risk of deleterious haematological and biochemical effects

Abstract

Atopic dermatitis is a complex, multifactorial disease. Treatment could be extremely long-term, even lifelong, and presents a real challenge for the veterinarians. Usually, atopic dermatitis involves a combination of approaches, including reactive therapy for acute conditions and proactive therapy for long-term management. A modern method is the allergen-specific immunotherapy (ASIT). The purpose of the present study is to prove that subcutaneously ad-ministered ASIT is a successful treatment that does not lead to any deleterious hematological and biochemical effects in dogs as opposed to long-term systemic glucocorticoids. Allergen-specific immunotherapy (ASIT) is considered to be the only treatment that can affect the course of the disease and not just suppress the symptoms.